

AstraZeneca PLC - Cambridge-based pharmaceutical and biotechnology company - Says Chief Executive Officer Pascal Soriot has been appointed a director ...


(Alliance News) - AstraZeneca PLC on Tuesday said it has completed its acquisition of Belgian biotechnology firm EsoBiotec SA, bolstering its cell the...


AstraZeneca PLC - Cambridge-based pharmaceutical and biotechnology company - Phase 3b Batura trial shows statistically significant and clinically mean...


(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US Preside...


(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.


(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-divi...


Biotechs fear changes at FDA could slow U.S. drug development *


EU, Denmark assess impact, warn of uncertainty *